New book by Larry Connors Click here Improve your trading - See how
Jul 07, 2008 -- Rudy Nutrition, Inc. (PINKSHEETS: RUNU | Quote | Chart | News | PowerRating) is pleased to announce that four-time Super Bowl Champion and former San Francisco 49ers Pro-Bowl offensive lineman Jesse Sapolu has joined the Rudy Beverage team as a celebrity endorser. Known as a true gentleman and a NFL ironman of his time, Jesse Sapolu's inspiring story truly exemplifies the Rudy Beverage "Dream Big. Never Quit." philosophy. Banned from playing sports by his doctors at a young age, Jesse persisted to chase his dream and eventually became a professional football player for the San Francisco 49ers. Jesse has been quoted saying, "When I played, the biggest thing we had was the belief inside our heads that we would be able to overcome anything." His success in pursuing his dream and excelling in his sport earned him four Super Bowl rings, several Pro Bowl invitations, and 12 division titles while playing 15 seasons for the 49ers. He currently serves as their Alumni Coordinator. Jesse's football career was not without additional challenges. In late 1996, Jesse's heart condition worsened and his doctors recommended that Jesse choose one of two options: undergo a relatively new surgery called the Ross procedure or retire. Not being the type to ever quit, Jesse chose to have the procedure. The very next fall, Jesse hit the field with the 49ers once again to become the first player in NFL history to not only undergo open-heart surgery, but to return from such a procedure and play successfully. Executive Vice-President of Sales Ron Scharf commented: "His inspirational story of success makes him a perfect fit for the Rudy team to help us gain exposure and drive sales, particularly in Northern California and throughout the Pacific." Jesse will be making personal appearances, and be featured in marketing and promotional materials, and advertising campaigns on behalf of Rudy Beverage. In the coming weeks, more nationally recognized and respected sports personalities who embody the Rudy message of "Dream Big. Never Quit." will be announced.
Jul 07, 2008 -- Lifeway Foods, Inc. (NASDAQ: LWAY), the country's leading manufacturer of kefir and a provider of other natural and organic dairy products, announced today that it is franchising its Starfruit "kefir boutique" cafe. The new retail concept debuted April 15th at 1745 W. Division Street in the trendy Wicker Park neighborhood in Chicago and serves as a prototype for it's national franchise program. The shop offers several flavors of frozen kefir with over 20 toppings as well as customized kefir parfaits, and smoothie-style kefir drinks. "Since announcing the initial opening of Starfruit, we have been bombarded with requests for franchise opportunities from all over the country," said Julie Smolyansky, President and CEO of Lifeway Foods, Inc. "Starfruit will capitalize on the renewed popularity of frozen yogurt shops while offering a healthier alternative with all the probiotic benefits of kefir and franchising the concept can help us grow the brand quickly." The expansion into retailing provides a new sales channel for Lifeway's products, coincides with the resurgence in the frozen yogurt category and offers an opportunity for Lifeway to promote the health benefits of its kefir products beyond grocery shelves. "Starfruit will capitalize on the renewed popularity of frozen yogurt shops while offering a healthier alternative with all the probiotic benefits of kefir," said Julie Smolyansky, President and CEO of Lifeway Foods Inc. "We have been pioneering leaders in the field of probiotics and kefir. This leadership will translate into the quality of the Starfruit product line. This is a promising diversification that will leverage our leadership in the kefir market, familiarize a whole new group of consumers with kefir as well as teach existing customers new ways to consume kefir, and provide a potentially very lucrative new revenue stream."
Jul 07, 2008 -- Unilever (NYSE: UN | Quote | Chart | News | PowerRating) is introducing the first functional shot that may help close the potassium gap. Promise SuperShots for blood pressure are essential fruit blend functional shots that provide a good source of potassium and are low in sodium. Each three-ounce Promise SuperShots contains 350 mg of potassium, similar to the amount contained in a serving of a fruit that is a good source of potassium, such as a small banana. Promise SuperShots fruit blends come in three flavors: strawberry banana, peach apricot, and mixed berry. "Promise SuperShots were designed to help adults who are concerned about managing their risk of high blood pressure by adding more potassium to their diet," said Douglas Balentine, Ph.D., Director of Nutrition and Health at Unilever North America. "Many Americans find it hard to not only get enough potassium but also from the recommended sources. This product line fits with the DASH eating plan and is an easy and convenient way to get closer to the recommended daily amount of potassium. This new product innovation is an example of Unilever's commitment to helping people stay healthy longer."
Jul 07, 2008 -- Labopharm Inc. (NASDAQ: DDSS | Quote | Chart | News | PowerRating) today announced that it has reacquired the sales and marketing rights to its once-daily tramadol product (Tradorec XL ) for the United Kingdom from Recordati Ireland Ltd. (Recordati). To promote its product in the UK, the Company will engage a contract sales organization and pursue a new licensing and distribution agreement with an appropriate marketing partner. "Our once-daily tramadol product is achieving strong market penetration, particularly in Spain, Italy and Canada, and we believe that this success can be replicated in the UK with the appropriate sales and marketing effort behind Tradorec XL ," said James R. Howard-Tripp, President and Chief Executive Officer, Labopharm Inc. "The market for tramadol products in the UK continues to exhibit strong growth and we are confident in both our product and its prospects in this market." Under its agreement with Recordati to reacquire the UK rights to its once-daily tramadol product, Labopharm will continue to use the brand name Tradorec XL in marketing its product. Labopharm will also receive a (euro)700,000 milestone from Recordati upon termination of Recordati's rights. Labopharm is in discussions to finalize an agreement with a contract sales organization to promote Tradorec XL in the UK. The Company is also in discussions to establish a licensing and distribution agreement with a new marketing partner.
Market Wrap for July 7th Stocks were whipsawed in the week's opening session. Monday began with strong gains as the Dow Jones Industrial Average climbed more than 100 points before swinging to a loss of more than 100 points. The total swing between its high of the day and its low was 278 points. Similar volatility was seen in the other major indices, yet buyers returned late in the session to lift the major indices off their worst levels of the session. A lack of concerted leadership during trading contributed to the broad-based declines. Financials were the worst performer yet again. The financial sector had been up more than 1.0% early on, but fell to a loss of 4.0% in the afternoon. It closed 3.2% lower. The drop among financial stocks precipitated a broad-based decline, which pulled each of the major indices into bear market territory. That is, down 20% from peaks that were reached several months ago. The afternoon's dour tone overshadowed a drop in oil prices, which closed its session on the Nymex more than $4 lower at $141.23 per barrel. The drop is the largest single-session dip in weeks. A lack of earnings news led participants to act on corporate news. Word that Microsoft (MSFT 26.03, +0.05) is willing to enter discussions with Yahoo! (YHOO 23.91, +2.56) if Yahoo replaces its board of directors lifted YHOO to its best level in recent weeks. In a similar vein, InBev is planning an effort that would replace the Anheuser-Busch (BUD 61.74, +0.07) board of directors, according to reports. Takeover attempts by InBev have been blocked by the St. Louis-based brewer's board. Elsewhere, General Electric's (GE 27.38, +0.47) NBC Universal is joining Blackstone Group (BX 16.77, -0.46) and Bain Capital to purchase The Weather Channel for $3.5 billion. On the selling side, The Wall Street Journal reported that Merrill Lynch (MER 30.36, -0.76) may be moving closer to selling its stakes in holdings like Bloomberg and BlackRock (BLK 164.21, -5.36), while General Motors (GM 10.24. +0.12) may sell some of its brands and cut its employee headcount.
ABOUT INVESTSOURCE, INC.: WIN an 8 day 7 nights Caribbean Getaway, GO TO: www.investsourceinc.com.
To hear "The Fastest 60 Seconds in the Small-Cap Market," please go to www.ceo-corner.com This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation to buy or sell securities. InvestSource, Inc. has prepared all material herein based upon information believed to be reliable. The information contained herein is not guaranteed by InvestSource, Inc. to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this release have not given an opinion or approved the statements made in this release.
InvestSource, Inc. is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. InvestSource, Inc. affiliates, officers, directors and employees may also have bought, or may buy the shares discussed in this opinion and may profit in the event of a rise in value. InvestSource, Inc. will not advise as to when it decides to sell and does not, and will not, offer any opinion as to when others should buy or sell; each investor must make that decision based on his or her judgment of the market. Please consult your broker before purchasing or selling any securities mentioned herein. To view full disclaimers, please go to http://investsourceinc.com/php/disclaimer.php (disclaimers).
CONTACT: InvestSource, Inc e-mail: info@investsourceinc.com WWW: http://www.investsourceinc.com
M2 Communications Ltd disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to info@m2.com.
More News:
Market Updates |
Stock Alerts |
All Trading News |
Stock Index
About TradingMarkets | Contact | Advertise | Careers | Link to Us | Site Map | Help | Terms & Conditions | Privacy Policy | Return Policy | Testimonials | Feedback
The Connors Group, Inc. ("Company") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities or currencies customers should buy or sell for themselves. The analysts and employees or affiliates of Company may hold positions in the stocks, currencies or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities and/or currencies. The Company, the authors, the publisher, and all affiliates of Company assume no responsibility or liability for your trading and investment results. Factual statements on the Company's website, or in its publications, are made as of the date stated and are subject to change without notice.
It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by Company are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of Company's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on Company's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.
HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN INHERENT LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING AND MAY NOT BE IMPACTED BY BROKERAGE AND OTHER SLIPPAGE FEES. ALSO, SINCE THE TRADES HAVE NOT ACTUALLY BEEN EXECUTED, THE RESULTS MAY HAVE UNDER- OR OVER-COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFITS OR LOSSES SIMILAR TO THOSE SHOWN.
The Connors Group, Inc.
15260 Ventura Blvd., Ste. 2200
Sherman Oaks, CA 91403
© Copyright 2009 The Connors Group, Inc.
